Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dunais

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
AIDS Care|September 9, 2010
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trialL Bentz, P Enel, B Dunais, et al.
The Journal of Infection|October 22, 2002
Consensual treatment of plasmodium falciparum malaria does not lead to adequate quinine blood concentrationsP-M Roger, P Marty, L Prestifilippo, et al.
HIV Medicine|July 14, 2005
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?I Perbost, B Malafronte, C Pradier, et al.
Journal of Neurovirology|November 6, 2016
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replicationMatteo Vassallo, R Fabre, J Durant, et al.
HIV Medicine|May 19, 2015
Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activationM Vassallo, J Durant, C Lebrun-Frenay, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
AIDS Care|September 9, 2010
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trialL Bentz, P Enel, B Dunais, et al.
The Journal of Infection|October 22, 2002
Consensual treatment of plasmodium falciparum malaria does not lead to adequate quinine blood concentrationsP-M Roger, P Marty, L Prestifilippo, et al.
HIV Medicine|July 14, 2005
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?I Perbost, B Malafronte, C Pradier, et al.
Journal of Neurovirology|November 6, 2016
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replicationMatteo Vassallo, R Fabre, J Durant, et al.
HIV Medicine|May 19, 2015
Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activationM Vassallo, J Durant, C Lebrun-Frenay, et al.
Pageof 3